Santen Receives Canadian Drug Expert Committee Reimbursement Recommendation for Verkazia Eye Drops
11/22/2019
Santen Canada announced that the Canadian Agency for Drugs and Technologies in Health (CADTH) Canadian Drug Expert Committee (CDEC) released a reimbursement recommendation for Verkazia (cyclosporine 0.1%) eye drops.
This reimbursement recommendation marks an important step towards providing patients access to this new formulation of cyclosporine eye drops in Canada. Provincial jurisdictions are the final decision makers on public reimbursement.
For more information please visit CADTH website: CDEC Recommendation & CADTH review report(s)